AdAlta Limited (ASX: 1AD) is an Australian public biotechnology company focused on the development and commercialisation of its i-body technology platform that has generated a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases.
Existing Shareholders
Help us manage our environmental impact (and investment)
Nominate now to receive all security holder communications electronically
- Support your investment – reduce print/postal costs
- Receive communications quickly and securely
- Save paper and emissions – less printing/delivery
How?
Visit the Automic Registry Service. Log in or Register
- Visit Settings (bottom left of screen)
- Select Portfolio profile
- Select Communications Method: Electronic Only;
- Complete the contact name and email address fields, click Continue through to Review and Apply and start managing your portfolio online!
Stay up to date
Subscribe to AdAlta news alerts and updates, via our Stay in touch form.
Interested Investors
Stay up to date on AdAlta’s progress
Subscribe to AdAlta news alerts and updates, via our Stay in Touch form.
Visit our Investor Page or the ASX website